Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRED-AID: Prednisolone in Adrenal Insufficiency
NCT03936517Phase 3Unknown
- Sponsor
- Imperial College London
- Start
- Jul 2019
- Primary completion
- Feb 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prednisolone in adrenal insufficiency (AI) (2 arms), sponsored by Imperial College London. Primary endpoint: Change in concentration of Osteocalcin at Day 120. Status: unknown.
02
Drugs
prednisolone
03
Conditions
adrenal insufficiency (AI)
Beyond the preview
Go deeper on NCT03936517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03936517.